IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY
DEAD

Serial Number

88037659

Owner

BTG International Limited

Attorney

Lori A. Ruhly

Filing Date

Jul 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY Trademark

Serial Number: 88037659

IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY is a trademark filed by BTG International Limited on July 13, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

BTG International Limited (35 trademarks)

5 Fleet Place
London EC4M 7RD , GB

Entity Type: 11

Trademark Details

Filing Date

July 13, 2018

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; radioactive substances for medical purposes, namely, microscopic radioactive beads for treatment of cancerous tumours, microscopic glass beads incorporating radioactive material for treatment of cancerous tumours, and radioactive glass beads; pharmaceutical preparations for use in chemotherapy

Surgical apparatus and instruments; medical apparatus and instruments for use in the diagnosis and treatment of cancer; Surgical and medical apparatus and instruments, namely, drug delivery systems; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; implantable radiation therapy devices, namely, microscopic glass beads incorporating radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours, and radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment; surgical, medical and medical diagnostic devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts for all of the aforesaid goods

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 13, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 13, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 26, 2025 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 2, 2024 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 28, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 12, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 15, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 14, 2023 RCSC
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2023 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 3, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 9, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 9, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 9, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 9, 2020 RCSC
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 30, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 30, 2020 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 9, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 5, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 5, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 5, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 2, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2019 CRFA
ASSIGNED TO LIE
May 19, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 31, 2018 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 19, 2018 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 19, 2018 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 19, 2018 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2018 NWOS
NEW APPLICATION ENTERED
Jul 17, 2018 NWAP